semaglutide headache side effects Effects: What to Expect in the First Weeks Semaglutide Headaches: Causes, Prevention &

Diarrhea Affects roughly 12 to 17 percent of tirzepatide users across all doses

Who manufactures phentermine

Kati Kaushal Patient, California Faith came out today to give me some fluids

Why this matters BIG TIME: Dual opportunity unlocked Covers Type-2 Diabetes and Chronic Weight Management two of Indias fastest-growing therapy segments Patent expiry catalyst India patent expiry expected in March 2026, setting the stage for large-scale generic entry Affordability revolution Generic semaglutide could be up to 70% cheaper, dramatically improving patient access Branded for impact Sematrinity Diabetes care Noveltreat Weight management Ready-to-use innovation Weekly dosing via prefilled pens (0.25 mg to 2.4 mg) convenience + adherence First-wave advantage Early DCGI approval gives Sun Pharma a strong launch edge in a fiercely competitive GLP-1 race Macro tailwinds Rising obesity, diabetes prevalence & metabolic disorders = long-term demand visibility Strategic takeaway: This isnt just another generic launch its a strategic bet on the future of metabolic healthcare in India